Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 2
2020 4
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.
Watabe T, Liu Y, Kaneda-Nakashima K, Shirakami Y, Lindner T, Ooe K, Toyoshima A, Nagata K, Shimosegawa E, Haberkorn U, Kratochwil C, Shinohara A, Giesel F, Hatazawa J. Watabe T, et al. Among authors: kaneda nakashima k. J Nucl Med. 2020 Apr;61(4):563-569. doi: 10.2967/jnumed.119.233122. Epub 2019 Oct 4. J Nucl Med. 2020. PMID: 31586001 Free PMC article.
Role of Mel1/Prdm16 in bone differentiation and morphology.
Kaneda-Nakashima K, Igawa K, Suwanruengsri M, Naoyuki F, Ichikawa T, Funamoto T, Kurogi S, Sekimoto T, Yamashita Y, Chosa E, Yamaguchi R, Morishita K. Kaneda-Nakashima K, et al. Exp Cell Res. 2022 Jan 15;410(2):112969. doi: 10.1016/j.yexcr.2021.112969. Epub 2021 Dec 7. Exp Cell Res. 2022. PMID: 34883111
α-Emitting cancer therapy using 211 At-AAMT targeting LAT1.
Kaneda-Nakashima K, Zhang Z, Manabe Y, Shimoyama A, Kabayama K, Watabe T, Kanai Y, Ooe K, Toyoshima A, Shirakami Y, Yoshimura T, Fukuda M, Hatazawa J, Nakano T, Fukase K, Shinohara A. Kaneda-Nakashima K, et al. Cancer Sci. 2021 Mar;112(3):1132-1140. doi: 10.1111/cas.14761. Epub 2021 Jan 22. Cancer Sci. 2021. PMID: 33277750 Free PMC article.
Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer.
Watabe T, Kaneda-Nakashima K, Ooe K, Liu Y, Kurimoto K, Murai T, Shidahara Y, Okuma K, Takeuchi M, Nishide M, Toyoshima A, Shinohara A, Shirakami Y. Watabe T, et al. Among authors: kaneda nakashima k. Ann Nucl Med. 2021 Jun;35(6):702-718. doi: 10.1007/s12149-021-01612-9. Epub 2021 Apr 19. Ann Nucl Med. 2021. PMID: 33871803 Free PMC article.
Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model.
Liu Y, Watabe T, Kaneda-Nakashima K, Shirakami Y, Naka S, Ooe K, Toyoshima A, Nagata K, Haberkorn U, Kratochwil C, Shinohara A, Hatazawa J, Giesel F. Liu Y, et al. Among authors: kaneda nakashima k. Eur J Nucl Med Mol Imaging. 2021 Sep 18. doi: 10.1007/s00259-021-05554-2. Online ahead of print. Eur J Nucl Med Mol Imaging. 2021. PMID: 34537893
11 results